Apellis Pharmaceuticals Inc (APLS)
44.88
-3.98
(-8.15%)
USD |
NASDAQ |
May 07, 11:04
Apellis Pharmaceuticals Total Return Level: 48.86 for May 6, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 06, 2024 | 48.86 |
May 03, 2024 | 47.46 |
May 02, 2024 | 47.49 |
May 01, 2024 | 46.05 |
April 30, 2024 | 44.19 |
April 29, 2024 | 47.84 |
April 26, 2024 | 49.86 |
April 25, 2024 | 47.93 |
April 24, 2024 | 49.93 |
April 23, 2024 | 48.72 |
April 22, 2024 | 47.64 |
April 19, 2024 | 47.53 |
April 18, 2024 | 47.51 |
April 17, 2024 | 48.03 |
April 16, 2024 | 51.82 |
April 15, 2024 | 51.50 |
April 12, 2024 | 51.79 |
April 11, 2024 | 55.73 |
April 10, 2024 | 56.84 |
April 09, 2024 | 55.12 |
April 08, 2024 | 53.81 |
April 05, 2024 | 55.91 |
April 04, 2024 | 56.05 |
April 03, 2024 | 56.95 |
April 02, 2024 | 55.70 |
Date | Value |
---|---|
April 01, 2024 | 59.71 |
March 28, 2024 | 58.78 |
March 27, 2024 | 58.49 |
March 26, 2024 | 59.00 |
March 25, 2024 | 55.53 |
March 22, 2024 | 55.39 |
March 21, 2024 | 56.61 |
March 20, 2024 | 55.52 |
March 19, 2024 | 56.92 |
March 18, 2024 | 56.26 |
March 15, 2024 | 56.74 |
March 14, 2024 | 56.48 |
March 13, 2024 | 57.36 |
March 12, 2024 | 58.50 |
March 11, 2024 | 60.69 |
March 08, 2024 | 61.63 |
March 07, 2024 | 62.44 |
March 06, 2024 | 60.94 |
March 05, 2024 | 62.47 |
March 04, 2024 | 64.63 |
March 01, 2024 | 63.89 |
February 29, 2024 | 61.97 |
February 28, 2024 | 64.05 |
February 27, 2024 | 69.35 |
February 26, 2024 | 71.73 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
17.91
Minimum
Mar 17 2020
93.31
Maximum
Jun 13 2023
46.25
Average
45.16
Median
Apr 26 2021
Total Return Level Benchmarks
Blueprint Medicines Corp | 106.25 |
Sarepta Therapeutics Inc | 135.04 |
Alnylam Pharmaceuticals Inc | 151.24 |
Ionis Pharmaceuticals Inc | 42.28 |
Madrigal Pharmaceuticals Inc | 236.10 |